Abstract
The aim of this study was to evaluate the frequency of seizures in systemic sclerosis (SSc) and to determine the clinical and laboratory features associated with their occurrence. Thirty-four SSc patients (ACR criteria) were analyzed by a standard interview, physical examination, and review of medical charts. Risk factors for seizures, clinical manifestations, associated co-morbidities and current treatment were evaluated. We identified 3 (8.8 %) SSc patients with seizures. A higher median age [61 (35–64) vs. 48 (27–71) years, p = 0.0005] and higher activity score [4.75 (4.5–5.0) vs. 2.5 (0–5–5) years, p = 0.006] were observed in SSc patients with seizures. No other clinical or laboratory feature was associated with the occurrence of seizure in this cohort. This study demonstrated a higher prevalence of seizures in SSc when compared to general population. Seizures were associated with older age and higher activity score in this cohort.
Similar content being viewed by others
References
Medsger TA Jr, Masi AT (1971) Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med 74:714–721
Gordon RM, Silverstein A (1970) Neurologic manifestations in progressive systemic sclerosis. Arch Neurol 22:126–134
Hietaharju A, Jääskeläinen S, Kalimo H, Hietarinta M (1993) Peripheral neuromuscular manifestations in systemic sclerosis (scleroderma). Muscle Nerve 16:1204–1212
Mohamed RHA, Nassef AA (2010) Brain magnetic resonance imaging findings in patients with systemic sclerosis. Int J Rheum Dis 13:61–67
Mohammed RHA, Sabry YY, Nasef AA (2011) Brain MRI screening showing evidences of early central nervous system involvement in patients with systemic sclerosis. Rheumatol Int 31:667–671
Jimenez-Moreno J, Selva-O’Callaghan A, Rovira-Cañellas A, Solans-Laque R, Len O, Olias M, Fonollosa-Pla V, Vilardell-Tarres M (1998) Trigeminal sensory neuropathy in systemic sclerosis. Br J Rheumatol 37:587–589
Bondavalli P, Parodi A, Rebora A (1997) Peripheral neuropathy in scleroderma successfully treated with amitriptyline. Int J Dermatol 36:234–235
Allanore Y, Zuber M, Kahan A (2002) Brachial plexopathy associated with systemic sclerosis. Clin Rheumatol 21:401–402
Hietaharju A, Jääskeläinen S, Hietarinta M, Frey H (1993) Central nervous system involvement and psychiatric manifestations in systemic sclerosis (scleroderma): clinical and neurophysiological evaluation. Acta Neurol Scand 87:382–387
Navon P, Halevi A, Brand A, Branski D, Rubinow A (1993) Progressive systemic sclerosis sine scleroderma in a child presenting as nocturnal seizures and Raynaud’s phenomenon. Acta Paediatr 82:122–123
Ishii A, Oguni E, Yoshizawa T, Mizusawa H, Muraki R (1993) A case of progressive systemic sclerosis with Sjögren’s syndrome presenting with coma, convulsion and bilateral thalamic hypodensity on computed tomography. Rinsho Shinkeigaku 33:966–970
Uriuhara A, Morita S, Yamada K, Masugi J, Yamada H, Hasegawa Y, Yokono K, Kasuga M (1997) A case of MPO-ANCA positive progressive systemic sclerosis with status epileptics. Ryumachi 37:483–486
Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980). Arthritis Rheum 23:581–590
LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205
Furst DE, Clements PJ, Steen VD et al (1998) The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol 25:84–88
Valentini G, Silman AJ, Veale D (2003) Assessment of disease activity. Clin Exp Rheumatol 21(3 Suppl 29):S39–S41
Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21(3 Suppl 29):S42–S46
Benseñor IM, Lotufo PA, Menezes PR, Scazufca M (2010) Subclinical hyperthyroidism and dementia: the São Paulo Ageing & Health Study (SPAH). BMC Public Health 10:298
Blume WT, Lüders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr (2001) Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 42:1212–1218
Fisher RS, van Emde Boas W, Blume W et al (2005) Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46:470–472
Appenzeller S, Cendes F, Costallat LT (2004) Epileptic seizures in systemic lupus erythematosus. Neurology 63:1808–1812
Das CP, Prabhakar S, Lal V, Kharbanda PS (2002) Scleroderma, stroke, optic neuropathy: a rare association. Neurol India 50:504–507
Clements PJ, Furst DE, Campion DS et al (1978) Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum 21:62–71
Averbuch-Heller Steiner I, Abramsky O (1992) Neurologic manifestation of progressive systemic sclerosis. Arch Neurol 49:1292–1295
Lucivero V, Mezzapesa DM, Petruzzellis M, Carella A, Lamberti P, Federico F (2004) Ischaemic stroke in progressive systemic sclerosis. Neurol Sci 25:230–233
Sardanelli F, Lozzelli A, Cotticelli B et al (2005) White matter hyperintensities on brain magnetic resonance in systemic sclerosis. Ann Rheum Dis 64:777–779
Pathak R, Gabor AJ (1991) Scleroderma and central nervous system vasculitis. Stroke 22:410–413
Fornes P, Chatellier J, Emmerich J et al (2002) Central nervous system involvement in scleroderma. Ann Med Interne 153:179–182
Andonopoulos AP, Maraziotis T, Yarmenitis S et al (1998) Multiple spontaneous intracerebral haemorrhage in a patient with progressive systemic sclerosis. Rev Rheum (ENGL ED) 65:437–440
Cutolo M, Nobili F, Sulli A et al (2000) Evidence of cerebral hypoperfusion in scleroderma patients. Rheumatology 39:1366–1373
Tuffanelli DL, Winkelmann RK (1961) Systemic scleroderma. Arch Dermatol 84:359–371
Forsgren L, Beghi E, Oun A, Sillanpää M (2005) The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 12(4):245–253
Grosso S, Fioravanti A, Biasi G, Conversano E, Marcolongo R, Morgese G, Balestri P (2003) Linear scleroderma associated with progressive brain atrophy. Brain Dev 25:57–61
Kister I, Inglese M, Laxer R, Herbert J (2008) Neurologic manifestations of localized scleroderma. Neurology 71:1538–1545
Stone J, Franks AJ, Guthrie JA, Johnson MH (2001) Scleroderma ‘en coup de sabre’: pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 70:382–385
Menni S, Marzano AV, Passoni E (1997) Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea. Pediatr Dermatol 14:113–116
Blaszczyk M, Jablonska S (1999) Linear scleroderma en Coup de Sabre: relationship with progressive facial hemiatrophy (PFH). Adv Exp Med Biol 455:101–104
Dupont S, Catala M, Hasboun D, Semah F, Baulac M (1997) Progressive facial hemiatrophy and epilepsy: a common underlying dysgenetic mechanism. Neurology 48:1013–1018
Acknowledgments
Carvalho JF received grants from Federico Foundation and CNPq (300665/2009-1); Apenzeller S received grants from CNPq (2009/06049-6) and FAPESP (2008/02917-0).
Conflict of interest
The authors declare no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Araújo, F.G., Amaral, T.N., Appenzeller, S. et al. Seizures in systemic sclerosis. Rheumatol Int 33, 1721–1724 (2013). https://doi.org/10.1007/s00296-012-2630-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2630-y